Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Torrentino Madamet, Marylin ^a,b,c   Fall, Becaye ^d   Benoit, Nicolas ^a,b,c   Camara, Cheikhou ^d   Amalvict, Rémy ^a,b,c   Fall, Mansour ^d   Dionne, Pierre ^d   Fall, Kadidiatou Ba ^d   Nakoulima, Aminata ^d   Diatta, Bakary ^d   Dieme, Yaya ^d   Menard, Didier ^e   Wade, Boubacar ^d   Pradines, Bruno ^b,c,d,f  

^a LAVERAN MILITARY TEACHING HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c Centre National de Reference du Paludisme   (France)

^d HÔPITAL PRINCIPAL DE DAKAR   (Senegal)

^e INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^f INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

Author keywords

Anti malarial drug; artemisinin; K13 propeller; Malaria; Molecular marker; Plasmodium falciparum; Resistance; Senegal

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ASPARAGINE; LYSINE; QUININE; SERINE; THREONINE; ANTIMALARIAL AGENT; ARTEMISIN; ARTEMISININ DERIVATIVE; LACTONE; PROTOZOAL DNA; PROTOZOAL PROTEIN;

ANTIMALARIAL DRUG RESISTANCE; APICOMPLEXA; CODON; FEMALE; GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; K13 GENE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MOLECULAR GENETICS; NONHUMAN; PARASITE IDENTIFICATION; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; REVIEW; SEASON; SENEGAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHEAST ASIA; AMINO ACID SUBSTITUTION; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECTS; DRUG RESISTANCE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MISSENSE MUTATION; PARASITOLOGY;

AMINO ACID SUBSTITUTION; ANTIMALARIALS; ARTEMISININS; DNA, PROTOZOAN; DRUG RESISTANCE; GENOTYPE; HUMANS; LACTONES; MALARIA, FALCIPARUM; MUTATION, MISSENSE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; SENEGAL; SEQUENCE ANALYSIS, DNA;

EID: 84925347208     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-472     Document Type: Review

References (24)

1. Gadiaga L, Machault V, Pagès F, Gaye A, Jarjaval F, Godefroy L, Cissé B, Lacaux JP, Sokhna C, Trape JF, Rogier C: Conditions of malaria transmission in Dakar from 2007 to 2010. Malar J 2011, 10:312.
2. Drame PM, Machault V, Diallo A, Cornélie S, Poinsignon A, Lalou R, Sembène M, Dos Santos S, Rogier C, Pagès F, Le Hesran JY, Remoué F: IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar, Senegal. Malar J 2012, 11:72.
3. Diallo A, Ndam NT, Moussiliou A, Dos Santos S, Ndonky A, Borderon M, Oliveau S, Lalou R, Le Hesran JY: Asymptomatic carriage of Plasmodium in urban Dakar: the risk of malaria should not be underestimated. PlosOne 2012, 7:31300.
4. Ministère de la Santé et de la Prévention: Rapport sur la morbidité et la mortalité palustre au Sénégal en 2008. Dakar: Programme National de Lutte contre le Paludisme; 2010. http://www.pnlp.sn/UserFiles/File/donnee.pdf.
5. Ndiaye JLA, Faye B, Gueye A, Tine R, Ndiaye D, Tchania C, Ndiaye I, Barry A, Cisse B, Lameyre V, Gaye O: Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Malar J 2011, 10:237.
6. Thiam S, Thior M, Faye B, Diouf ML, Diouf MB, Diallo I, Fall FB, Ndiaye JL, Albertini A, Lee E, Jorgensen P, Gaye O, Bell D: Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests. PLoS One 2011, 6:18419.
7. Cissé B, Cairns M, Faye E, Ndiaye O, Faye B, Cames C, Cheng Y, Ndiaye M, Lô AC, Simondon K, Trape JF, Faye O, Ndiaye JL, Gaye O, Greenwood B, Milligan P: Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS One 2009, 4:7164.
8. Cissé B, Sokhna C, Boulanger D, Miler J, Bâ el H, Richardson K, Hallett R, Sutherland C, Simondon K, Simondon F, Alexander N, Gaye O, Targett L, Greenwood B, Trape JF: Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomized, placebo-controlled, double-blind trial. Lancet 2006, 367:659-667.
9. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwrong M, Chotivanish K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009, 361:455-467.
10. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM: Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 2008, 359:2619-2620.
11. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Moo LI, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NPJ, White NJ, Anderson TJC, Nosten F: Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012, 379:1960-1966.
12. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Seng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jttamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han KT, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, et al: Spread of artemisinin resistance in Plasmodium falciparum malaria. N Eng J Med 2014, 371:411-423.
13. Mita T, Venkatesan M, Ohashi J, Culleton R, Takahashi N, Tsukahara T, Ndounga M, Dysoley L, Ends H, Hombhanje F, Ferreira MU, Plowe CV, Tanabe K: Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations. J Infect Dis 2011, 204:1980-1988.
14. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ: Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002, 418:320-323.
15. Ariey F, Witkowsky B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D: A molecular marker of artemisinin-resistant Plasmodium falciparum. Nature 2014, 505:50-55.
16. Amaratunga C, Witkowski B, Khim N, Menard D, Fairhurst RM: Artemisinin resistance in Plasmodium falciparum. Lancet Infect Dis 2014, 14:449-450.
17. Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, Fukuda MM, Hien TT, Mayxay M, Noedl H, Nosten F, Kyaw MP, Thuy Nhien NT, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Ariey F, Mercerau-Puijalon O, Menrad D, Newton PN, Khanthavong M, Hongvanthong B, Staezengruber P, Fuehrer HP, Swoboda P, Khan WA, Phyo AP, et al: Independent emergence of Plasmodium falciparum artemisinin resistance mutations in Southeast Asia. J Infect Dis 2014, [Epub ahead of print].
18. Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, Lim P, Mao S, Sopha C, Sam B, Anderson JM, Meng Chuor C, Taylor WRJ, Suon S, Mercereau-Puijalon O, Fairhurst RM, Ménard D: Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis 2013, 13:1043-1049.
19. Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A, Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Ménard D: Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in Western Cambodia. Antimicrob Agents Chemother 2013, 57:914-923.
20. Ghorbal M, Gorman M, Macpherson CR, Martins RM, Scherf A, Lopez-Rubio JJ: Genome editing in the human malaria parasite Plasmodium falciparum using the CRISP-Cas9 system. Nature Biotech 2014, 32:819-821.
21. Conrad MD, Bigira V, Kapisi J, Muhindo M, Kamya MR, Havlir DV, Dorsey G, Rosenthal PJ: Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. PLoS One 2014, 9:105690.
22. Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Ama Moor V, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimdé A, Same-Ekobo A, Gaye O: Randomized, multicentre assessment of the efficacy and safety of ASAQ-a fixed dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar J 2009, 8:125.
23. Sylla K, Abiola A, Kouly Tine RC, Faye B, Sow D, Ndiaye JL, Ndiaye M, Lo MC, Folly K, Ndiaye LA, Gaye O: Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance. Malar J 2013, 13:598.
24. Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, Tagbor H, Williams J, Bojang K, Njie F, Desai M, Kariuki S, Gutman J, Mathanga D, Martensson A, Ngasala B, Conrad MD, Rosenthal PJ, Tshefu AK, Moormann AM, Vulule JM, Doumbo OK, ter Kuile FO, Meshnick SR, Bailey JA, Juliano JJ: Absence of putative Plasmodium falciparum artemisinin resistance mutations in sub-Saharan Africa: A molecular epidemiology study. J Infect Dis 2014, [Epub ahead of print].